What’s Happening to Drug Supply Chains
The pharmaceutical industry is heavily dependent on global shipping routes that pass through or near the conflict zone:
- Pharma raw material costs surged 20-30% in just two weeks after the conflict began (India.com, March 12)
- Air freight costs spiked 400% in the affected region, hitting pharmaceutical exports hard (LabNews)
- Indian pharma exports could see $600 million in losses — India is the world’s largest supplier of generic drugs (The Week India, March 11)
Which Medicines Are Most at Risk
Highest risk for price increases or shortages:
- Vitamins and nutritional supplements (many raw materials from Asia)
- Antibiotics (significant manufacturing in India and China)
- Generic prescription drugs (India supplies ~40% of US generics)
- Over-the-counter pain relievers and fever reducers
Moderate risk:
- Brand-name drugs with domestic manufacturing
- Specialty medications with established stockpiles
Lower risk:
- Locally manufactured drugs
- Medications with diverse supply chains
Country-Specific Impact
Pakistan: Only about 2 months of medicine stock remaining, creating urgent supply concerns (Pakistan Today, March 9)
India: As a major manufacturer AND exporter, India faces both higher input costs and disrupted shipping routes for exports
United States: Dependent on Indian and Chinese generics. Prices for common prescriptions likely to rise
Europe: Similar exposure through Indian generic suppliers and Asian raw material sources
What You Can Do
- Don’t panic-buy medications — hoarding can worsen shortages for everyone
- Talk to your doctor about 90-day prescriptions if you take regular medications
- Ask your pharmacist about alternative brands or generics that may be less affected
- Check if your medications are domestically manufactured — these are less likely to be disrupted
- Review your health insurance to understand your out-of-pocket maximum
Sources: India.com, The Week India, Pakistan Today, LabNews